Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462260) titled 'Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)' on March 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Sindh Institute of Cardiovascular Diseases

Condition: Pulmonary Hypertension Rheumatic Valvular Heart Disease

Intervention: Drug: Sildenafil 25 MG

Recruitment Status: Recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: August 1, 2025

Target Sample Size: 100

Countries of Recrui...